- Home
- KFFB vs GDTC Comparison
KFFB vs GDTC Comparison
Compare KFFB & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFFB
- GDTC
- Stock Information
- Founded
- KFFB 2005
- GDTC 2018
- Country
- KFFB United States
- GDTC Singapore
- Employees
- KFFB N/A
- GDTC N/A
- Industry
- KFFB Savings Institutions
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- KFFB Finance
- GDTC Health Care
- Exchange
- KFFB Nasdaq
- GDTC Nasdaq
- Market Cap
- KFFB 25.9M
- GDTC 21.5M
- IPO Year
- KFFB 2005
- GDTC 2023
- Fundamental
- Price
- KFFB $3.76
- GDTC $2.18
- Analyst Decision
- KFFB
- GDTC Buy
- Analyst Count
- KFFB 0
- GDTC 1
- Target Price
- KFFB N/A
- GDTC $5.00
- AVG Volume (30 Days)
- KFFB 1.5K
- GDTC 13.2K
- Earning Date
- KFFB 11-11-2025
- GDTC 01-01-0001
- Dividend Yield
- KFFB N/A
- GDTC N/A
- EPS Growth
- KFFB N/A
- GDTC N/A
- EPS
- KFFB N/A
- GDTC N/A
- Revenue
- KFFB $8,308,000.00
- GDTC $368,838.00
- Revenue This Year
- KFFB N/A
- GDTC $5.37
- Revenue Next Year
- KFFB N/A
- GDTC N/A
- P/E Ratio
- KFFB N/A
- GDTC N/A
- Revenue Growth
- KFFB 13.79
- GDTC N/A
- 52 Week Low
- KFFB $1.96
- GDTC $1.20
- 52 Week High
- KFFB $3.97
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- KFFB 75.63
- GDTC 63.22
- Support Level
- KFFB $3.12
- GDTC $1.82
- Resistance Level
- KFFB $3.44
- GDTC $2.27
- Average True Range (ATR)
- KFFB 0.07
- GDTC 0.09
- MACD
- KFFB 0.04
- GDTC 0.03
- Stochastic Oscillator
- KFFB 77.32
- GDTC 80.00
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.